The most recent research has focused on the molecular profile of PC, highlighting biomarkers and mutations possibly associated with the development and progression of PC, such as KRAS, MSI, TMB-H, BRAF, NTRK, and RET [98,99]. This evidence concerns the gene BRAF and pachyonychia congenita.